Fusion Pharmaceuticals
recognizing the potential of tats as next generation with collaboration | Fusion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
21 of 26
Related slides by other companies
Aeglea BioTherapeutics
Mergers and Acquisitions
June 2023
we plan to rapidly advance combination programs in parallel with in phase maintenance newton | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
May 2023
program overview | Aeglea BioTherapeutics
MindMed
Investor Presentation
November 2024
key highlights of program | MindMed
MindMed
Investor Presentation
December 2024
for gad phase program overview | MindMed
Other recent decks by Fusion Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
IPO
June 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights